CD44 and breast cancer: Furthermore, Ge et al. [8] revealed that SLC34A2 induced chemo-resistance in CD44+ CD24− breast cancer stem cell-like cells via Bmi1-ABCC5 signaling, which implies that SLC34A2 may be included in chemo-resistance in breast cancer.